Liver Cancer 2.0

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2023 Dec 23

PMID 38139103

Authors

Hiroaki Taniguchi

Affiliations

Soon will be listed here.

Abstract

Liver cancer, specifically hepatocellular carcinoma (HCC), is a major global health concern due to its high prevalence in many countries [...].

Citing Articles

Nanotechnology for the Diagnosis and Treatment of Liver Cancer.

Cai Y, Wang W, Jiao Q, Hu T, Ren Y, Su X Int J Nanomedicine. 2024; 19:13805-13821.

PMID: 39735328 PMC: 11681781. DOI: 10.2147/IJN.S490661.

Single-cell RNA sequencing analysis reveals potential key prognostic markers in hepatocellular carcinoma.

Cui H, Yang W Discov Oncol. 2024; 15(1):747.

PMID: 39633216 PMC: 11618547. DOI: 10.1007/s12672-024-01646-1.

Research Progress with Atractylone as an Antitumor Agent.

Yao Y, Shen G, Luo J, Wang J, Xu Z, Wang H Molecules. 2024; 29(22).

PMID: 39598839 PMC: 11597220. DOI: 10.3390/molecules29225450.

Cinnamaldehyde: Pharmacokinetics, anticancer properties and therapeutic potential (Review).

Han R, Li X, Gao X, Lv G Mol Med Rep. 2024; 30(3).

PMID: 38994757 PMC: 11267250. DOI: 10.3892/mmr.2024.13287.

Genetic screening of liver cancer: State of the art.

Peruhova M, Banova-Chakarova S, Miteva D, Velikova T World J Hepatol. 2024; 16(5):716-730.

PMID: 38818292 PMC: 11135278. DOI: 10.4254/wjh.v16.i5.716.

References

Jin J, Kouznetsova V, Kesari S, Tsigelny I . Synergism in actions of HBV with aflatoxin in cancer development. Toxicology. 2023; 499:153652. DOI: 10.1016/j.tox.2023.153652. View

Jacob R, Prince D, Kench C, Liu K . Alcohol and its associated liver carcinogenesis. J Gastroenterol Hepatol. 2023; 38(8):1211-1217. DOI: 10.1111/jgh.16248. View

Hamid A, Tesfamariam I, Zhang Y, Zhang Z . Aflatoxin B1-induced hepatocellular carcinoma in developing countries: Geographical distribution, mechanism of action and prevention. Oncol Lett. 2013; 5(4):1087-1092. PMC: 3629261. DOI: 10.3892/ol.2013.1169. View

Rich N . Changing Epidemiology of Hepatocellular Carcinoma Within the United States and Worldwide. Surg Oncol Clin N Am. 2023; 33(1):1-12. DOI: 10.1016/j.soc.2023.06.004. View

Pugliese N, Alfarone L, Arcari I, Giugliano S, Parigi T, Rescigno M . Clinical features and management issues of NAFLD-related HCC: what we know so far. Expert Rev Gastroenterol Hepatol. 2022; 17(1):31-43. DOI: 10.1080/17474124.2023.2162503. View